The relationship between serum adiponectin levels with the presence and severity of coronary artery disease

Archives of Iranian Medicine

Volumn 15, Issue 10, 2012, Pages 611-616

  Shams, Mesbah ^a   Kazerouni, Akbar Rasekhi ^b   Ostovan, Mohammad Ali ^b   Omrani, Gholamhossein Ranjbar ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adiponectin; Coronary angiography; Coronary artery disease

Indexed keywords

ADIPONECTIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENSINI SCORE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; RISK ASSESSMENT; SCORING SYSTEM;

ADIPONECTIN; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CORONARY ANGIOGRAPHY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84867279062     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to c1q, produced exclusively in adipocytes. J Biol Chem. 1995; 270: 26746-26749.
2. Chandran M, Phillips SA, Ciaraldi T, Henry RR. Adiponectin: more than just another fat cell hormone? Diabetes Care. 2003; 26: 2442-2450.
3. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001; 86: 1930-1935.
4. Trujillo ME, Scherer PE. Adiponectin-journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Medi. 2005; 87: 87-91.
5. Schulze MB, Rimm EB, Shai I, Rifai N, Hu FB. Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes. Diabetes Care. 2004; 27: 1680-1687.
6. Tschritter O, Fritsche A, Thamer C, Haap M, Shirkavand F, Rahe S, et al. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes. 2003; 52: 239-243.
7. Putz DM, Goldner WS, Bar RS, Haynes WG, Sivitz WI. Adiponectin and C-reactive protein in obesity, type 2 diabetes, and monodrug therapy Metabolism. 2004; 53: 1454-1461.
8. Brennan AM, Mantzoros CS. Leptin and adiponectin: their role in diabetes. Curr Diab Rep. 2007; 7: 1-2.
9. Mohan V, Deepa R, Pradeepa R, Vimaleswaran KS, Mohan A, Velmurugan K, et al. Association of low adiponectin levels with the metabolic syndrome-the Chennai Urban Epidemiology Study (CURES-4). Metabolism. 2005; 54: 476-481.
10. Spranger J, Kroke A, Mohlig M, Bergmann MM, Ristow M, Boeing H, et al. Adiponectin and protection against type 2 diabetes mellitus. Lancet. 2003; 361: 226-228.
11. Duncan BB, Schmidt MI, Pankow JS, Bang H, Couper D, Ballantyne CM, et al. Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes. 2004; 53: 2473-2478.
12. Otsuka F, Sugiyama S, Kojima S, Maruyoshi H, Funahashi T, Sakamoto T, et al. Hypoadiponectinemia is associated with impaired glucose tolerance and coronary artery disease in non-diabetic men. Circ J. 2007; 71: 1703-1709.
13. Ouchi N, Kihara S, Funahashi T, Nakamura T, Nishida M, Kumada M, et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation. 2003; 107: 671-674.
14. Komura N, Kihara S, Sonoda M, Maeda N, Tochino Y, Funahashi T, et al. Increment and impairment of adiponectin in renal failure. Cardio-vasc Res. 2010; 86: 471-477.
15. Chow WS, Cheung BM, Tso AW, Xu A, Wat NM, Fong CH, et al. Hypoadiponectinemia as a predictor for the development of hyperten-sion: a 5-year prospective study. Hypertension. 2007; 49: 1455-1461.
16. Okamoto Y, Arita Y, Nishida M, Muraguchi M, Ouchi N, Takahashi M, et al. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm Metab Res. 2000; 32: 47-50.
17. Tan KCB, Xu A, Chow WS, Lam MC, Ai VH, Tam SC, et al. Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation. J Clin Endocrinol Metab. 2004; 89: 765-769.
18. Shimabukuro M, Higa N, Asahi T, Oshiro Y, Takasu N, Tagawa T, et al. Hypoadiponectinemia is closely linked to endothelial dysfunction in men. J Clin Endocrinol Metab. 2003; 88: 3236-3240.
19. Sakuta H, Suzuki T, Yasuda H, Ito T. Adiponectin levels and cardiovascular risk factors in Japanese men with type 2 diabetes. Endocr J. 2005; 52: 241-244.
20. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol. 2004; 24: 29-33.
21. Kojima S, Funahashi T, Maruyoshi H, Honda O, Sugiyama S, Kawa-no H, et al. Levels of the adipocyte-derived plasma protein, adiponectin, have a close relationship with atheroma. Thromb Res. 2005; 115: 483-490.
22. Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol. 2003; 23: 85-89.
23. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA. 2004; 291: 1730-1737.
24. Nakamura Y, Shimada K, Fukuda D, Shimada Y, Ehara S, Hirose M, et al. Implications of plasma concentrations of adiponectin in patients with coronary artery disease. Heart. 2004; 90: 528-533.
25. Ouchi N, Kobayashi H, Kihara S, Kumada M, Sato K, Inoue T, et al. Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J Biol Chem. 2004; 279: 1304-1309.
26. Chen H, Montagnani M, Funahashi T, Shimomura I, Quon MJ. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem. 2003; 278: 45021-45026.
27. Arita Y, Kihara S, Ouchi N, Maeda K, Kuriyama H, Okamoto Y, et al. Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation. 2002; 105: 2893-2898.
28. Yamauchi T, Kamon J, Waki H, Imai Y, Shimozawa N, Hioki K, et al. Globular adiponectin protected ob/ob mice from diabetes and apo E-deficient mice from atherosclerosis. J Biol Chem. 2003; 278: 2461-2468.
29. Kato H, Kashiwagi H, Shiraga M, Tadokoro S, Kamae T, Ujiie H, et al. Adiponectin acts as an endogenous antithrombotic factor. Arterioscler Thromb Vasc Biol. 2006; 26: 224-230.
30. Shibata R, Ouchi N, Kihara S, Sato K, Funahashi T, Walsh K. Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of amp-activated protein kinase signaling. J Biol Chem. 2004; 279: 28670-28674.
31. Maahs DM, Ogden LG, Kinney GL, Wadwa P, Snell-Bergeon JK, Da-belea D, et al. Low plasma adiponectin levels predict progression of coronary artery calcification. Circulation. 2005; 111: 747-753.
32. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol. 1983; 51: 606.
33. Adamczak M, Rzepka E, Chudek J, Wiecek A. Ageing and plasma adiponectin concentration in apparently healthy males and females. Clin Endocrinol (Oxf). 2005; 62: 114-118.
34. Isobe T, Saitoh S, Takagi S, Takeuchi H, Chiba Y, Katoh N, et al. Influence of gender, age, and renal function on plasma adiponectin level: the Tanno and Sobetsu study. Eur J Endocrinol. 2005; 153: 91-98.
35. Miles EA, Rees D, Banerjee T, Cazzola R, Lewis S, Wood R, et al. Age-related increases in circulating inflammatory markers in men are independent of BMI, blood pressure, and blood lipid concentrations. Atherosclerosis 2008; 196: 298-305.
36. Hashimoto N, Kanda J, Nakamura T, Horie A, Kurosawa H, Hashimoto T, et al. Association of hypoadiponectinemia in men with early onset of coronary heart disease and multiple coronary artery stenoses. Metabolism. 2006; 55: 1653-1657.
37. von Eynatten M, Humpert PM, Bluemm A, Lepper PM, Hamann A, Allolio B, et al. High-molecular weight adiponectin is independently associated with the extent of coronary artery disease in men. Atherosclerosis. 2008; 199: 123-128.
38. Liang KW, Lee WJ, Lee WL, Ting CT, Sheu WHH. Decreased ratio of high- molecular-weight to total adiponectin is associated with angiographic coronary atherosclerosis severity but not restenosis. Clin Chim Acta 2009; 405: 114-118.
39. Sattar N, Wannamethee G, Sarwar N, Tchernova J, Cherry L, Wallace AM, et al. Adiponectin and coronary heart disease: a prospective study and metaanalysis. Circulation 2006; 114: 623-629.
40. Söderberg S, Colquhoun D, Keech A, Yallop J, Barnes EH, Pollicino C, et al. Leptin, but not adiponectin, is a predictor of recurrent cardiovascular events in men: results from the lipid study. Int J Obes (Lond). 2009; 33: 123-130.
41. von Eynatten M, Hamann A, Twardella D, Nawroth PP, Brenner H, Rothenbacher D. Atherogenic dyslipidaemia but not total- and high-molecular weight adiponectin are associated with the prognostic outcome in patients with coronary heart disease. Eur Heart J. 2008; 29: 1307-1315.
42. Rizza S, Clementi F, Porzio O, Cardellini M, Savo A, Serino M, et al. Adiponectin isoforms are not associated with the severity of coronary atherosclerosis but with undiagnosed diabetes in patients affected by stable CAD. Nutr Metab Cardiovasc Dis. 2009; 19: 54 60.
43. Sattar N, Watt P, Cherry L, Ebrahim S, Davey Smith G, Lawlor DA. High molecular weight adiponectin is not associated with incident coronary heart disease in older women: a nested prospective case-control study. J Clin Endocrinol Metab. 2008; 93: 1846-1849.
44. Krecki R, Krzeminska-Pakula M, Drozdz J, Szczesniak P, Peruga JZ, Lipiec P, et al. Relationship of serum angiogenin, adiponectin and re-sistin levels with biochemical risk factors and the angiographic severity of three-vessel coronary disease. Cardiol J. 2010; 17: 599-606.
45. Selcuka MT, Selcuka H, Temizhana A, Madena O, Saydamb GS, DoganaM, et al. Impact of plasma adiponectin levels to the presence and severity of coronary artery disease in patients with metabolic syndrome. Coron Artery Dis. 2008, 19: 79-84.
46. Hara K, Yamauchi T, Imai Y, Manabe I, Nagai R, Kadowaki T. Reduced adiponectin level is associated with severity of coronary artery disease. Int Heart J. 2007; 48: 149-153.
47. Wang XY, Guo YH, Guo LJ. Association between plasma adiponectin levels and coronary lesion complexity. Beijing Da Xue Xue Bao. 2007; 18: 599-602.
48. Milosz D, Czupryniak L, Saryusz-Wolska M, Zasadzinska G, Borkowska A, Cieplucha E, et al. Adiponectinemia, inflammatory process activity, and endothelial dysfunction in patients with type 2 diabetes and acute coronary syndrome with ST elevation in relation to the severity of lesions in the coronary arteries. Pol Arch Med Wewn. 2007; 117: 343-349.